title: Reply to McCulley et al., reports to FDA of fatal anaphylaxis associated with intravenous iron products.
authors.affiliation: Georgetown University School of Medicine, Baltimore, Maryland.
authors.forename: Michael
authors.initials: M
authors.lastname: Auerbach
authors.affiliation: University of California San Diego, La Jolla, California.
authors.forename: John
authors.initials: J
authors.lastname: Adamson
mesh_terms: D061605:Administration, Intravenous; D017277:Drug Approval / Q000379:methods*; D005260:Female; D006801:Humans; D007501:Iron / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D014481:United States
chemical_list: D007501:Iron